Experimental study on the application of a novel degradable calcium-phosphate coated magnesium alloy encircling bone plate in the internal fixation of rib fractures Authors: Qihong Huang, Ke Chen, Xuhui Liu, Fugang Qi, Keyuan Liu, Shu Yang, Xiangqing Ye, Sike Mo, Juan Liu, Bo Ye Published: 2026 ABSTRACT AbstractSevere rib fractures often require surgical plate fixation, but non-biodegradable implants typically necessitate a second surgery for removal. Although AZ31 magnesium alloy is a biodegradable medical material, its excessively rapid in vivo degradation makes it difficult to meet the requirements for fracture fixation in high-load, dynamic environments such as the ribs. To address this issue, we used surface modification technology to apply a calcium-phosphate coating onto a biodegradable AZ31 magnesium alloy rib plate and evaluated its degradation rate, fracture fixation effectiveness, and potential adverse effects through in vitro and in vivo experiments. The results showed that the degradation rate of the coated plate was significantly slower than that of the uncoated plate in both settings (p < 0.05). In animal models of rib fracture, the coated plate achieved better fracture alignment and healing morphology, with no significant adverse reactions observed during the 6-month postoperative follow-up. Surface modification with a calcium-phosphate coating effectively mitigated the problem of premature fixation failure caused by the overly rapid in vivo degradation of AZ31 magnesium alloy. The findings of this study provide a new perspective for the development of biodegradable internal fixation implants for rib fractures.Graphical Abstract Introduction Rib fracture is one of the most common types of thoracic trauma. In severe cases, it can lead to chest wall collapse, damage to thoracic or abdominal organs or blood vessels, thereby posing a significant threat to patient survival. For such critical cases, surgical intervention is indispensable, primarily involving fracture reduction and fixation using bone plates. However, the internal fixation materials currently widely used in clinical practice are predominantly made of non-biodegradable metals, such as titanium or nickel-titanium (Ni-Ti) alloys. The long-term retention of these foreign materials within the body can cause persistent physical discomfort and psychological anxiety in some patients. Furthermore, this often necessitates a secondary surgery for implant removal, which consequently increases the physical, psychological, and financial burden on patients and prolongs the overall treatment course [1]. Magnesium alloy, as a biodegradable medical implant material, has obtained the Conformité Européenne certification in the European Union for applications such as cardiovascular stents [2] and bone screws [3], demonstrating favorable clinical outcomes. However, the relatively high chemical reactivity of magnesium leads to a rapid degradation rate in the body, which can cause premature implant failure and consequently compromise fracture fixation [4, 5]. Consequently, biodegradable magnesium alloy screws are currently predominantly used for fracture fixation in low-load-bearing regions, such as the metacarpals, phalanges, and jawbone. Reports on their application in high-load-bearing areas like the ribs or long bones remain scarce. Notably, several studies have confirmed that constructing a protective Calcium-Phosphate (CaP) coating on the magnesium alloy surface is an effective strategy for regulating and decelerating its degradation rate [6–8]. However, translating this coating technology to the clinical scenario of rib fixation presents a more formidable challenge. As key bones constituting the thoracic cage and maintaining respiratory movement, ribs are subjected to continuous, low-amplitude, high-frequency cyclic loading generated by breathing, coughing, and physical activity [9, 10]. This places demands on the fatigue performance, interfacial stability, and maintenance of mechanical strength during degradation of the internal fixation device that far exceed those under static conditions. Existing coating performance data, based on static or low-load models, is insufficient to predict its long-term behavior in such a complex and dynamic environment. Therefore, we integrated a CaP coating prepared via the “Filtered Cathodic Vacuum Arc (FCVA) + chemical conversion” method with a customized AZ31 magnesium alloy “embracing-type” rib plate. We not only verified its fundamental corrosion resistance through systematic in vitro degradation experiments and electrochemical tests but also innovatively simulated physiological loading using a large-animal rib fracture model and conducted a systematic 6-month in vivo validation. This study comprehensively employed imaging, histology, degradation analysis, and blood biochemical monitoring, aiming to systematically evaluate the material’s performance in a complex environment. The goal is to provide new insights for the exploration of applying biodegradable internal fixation materials to high-load, dynamic anatomical sites. Materials and methods Experimental materials AZ31 magnesium alloy rib-embracing plate The base material was a customized AZ31 magnesium alloy plate (Dongguan Fuzhou Metal Materials Co., Ltd.) with initial dimensions of 50 mm in length, 34 mm in width, and 1 mm in thickness (Fig. 1a). The final rib-embracing plate, with dimensions of 50 mm in length, 13 mm in width, and 10 mm in height, was fabricated from this base plate through physical processing techniques including bending and shaping. The AZ31 magnesium alloy rib-embracing plate (a). The CaP-coated AZ31 magnesium alloy rib-embracing plate (b). Schematic diagram of rib fracture fixation in the three groups (c). Fixation using the CaP-coated AZ31 magnesium alloy embracing plate (d). Fracture reduction without any internal fixation (e). Fixation using the uncoated AZ31 magnesium alloy embracing plate (f). Fixation using the Ni-Ti shape memory alloy embracing plate (g) CaP-coated AZ31 magnesium alloy rib-embracing plate (Fig. 1b) A hybrid “FCVA deposition + chemical conversion” method was employed to construct CaP coatings on AZ31 magnesium alloy rib-embracing plates. The detailed operational procedures have been thoroughly described in our previous study [11] and a publicly available authorized patent [12]. Ni-Ti shape memory alloy rib-embracing plate A commercial Ni-Ti shape memory alloy rib-embracing plate, used as a control, was purchased from Shanghai Xinchang Shape Memory Alloy Technology Co., Ltd. Its appearance and dimensions were similar to those of the magnesium alloy plates. Fabrication of CaP coating on AZ31 magnesium alloy rib-embracing plate Deposition of FCVA pretreatment layer AZ31 magnesium alloy samples were fixed onto a rotating tray within the FCVA deposition chamber. The chamber background pressure was evacuated to 4 × 10⁻³ Pa using a mechanical pump and a molecular pump. After introducing argon gas, a bias voltage was applied to perform sputter cleaning on the AZ31 magnesium alloy substrate to remove trace surface oxides and contaminants. The deposition parameters are summarized in Table 1. Table 1FCVA Deposition ParametersParameterValueTarget MaterialMagnesiumDeposition Temperature20 °CBias Voltage−100 VCathode Target Arc Current90 AFiltered Duct Coil Current2.5 ASubstrate Rotation Speed4 rpmBackground Pressure4 × 10⁻³ PaPulse Bias Duty Cycle50%Deposition Time300 s FCVA Deposition Parameters Preparation of CaP coating via chemical conversion method 30 g of calcium nitrate tetrahydrate (Ca(NO3)2·4H2O) and 50 mL of phosphoric acid (H3PO4) were dissolved in 1 L of ultrapure water. The solution pH was adjusted to 2.0 using a concentrated sodium hydroxide solution (3 mol/L) to obtain the CaP chemical conversion solution. The AZ31 magnesium alloy samples pretreated with FCVA deposition were immersed in the aforementioned CaP conversion solution. After immersion at room temperature for 15 min, the samples were removed, gently rinsed with deionized water to remove residual solution, and subsequently dried in an oven at 50 °C for 4 h. Structural characterization and analysis The surface and cross-sectional morphology of the CaP-coated magnesium alloy samples were examined using a scanning electron microscope (SEM, ZEISS EVO MA10). The CaP coating was gently scraped off from the magnesium alloy substrate and then subjected to further microstructural analysis using transmission electron microscopy (TEM, FEI Tecnai F20). Functional groups within the coating were detected by a Fourier transform infrared (FTIR) spectrometer (Thermo Scientific Nicolet iN10) over a wavenumber range of 4000 to 400 cm⁻¹. The phase composition of the AZ31 magnesium alloy surface, before and after coating deposition, was analyzed using an X-ray diffractometer (XRD, Malvern Panalytical Empyrean Alpha 1) with a scanning diffraction angle (2θ) ranging from 10° to 80°. Electrochemical testing Tests were performed using a three-electrode system on a Reference 600+ electrochemical workstation. The coated sample served as the working electrode, a platinum plate as the counter electrode, and a saturated calomel electrode as the reference electrode. All measurements were conducted inside a Faraday cage. In vitro short-term immersion test Ten CaP-coated AZ31 magnesium alloy rib-embracing plates were assigned as the experimental group, and ten uncoated AZ31 magnesium alloy plates of the same design served as the control group. Each sample was individually immersed in a flask containing 150 mL of simulated body fluid (SBF, 0.01 mol/L phosphate-buffered saline). The liquid height was maintained at approximately five times the height of the sample. The flasks remained open to the ambient atmosphere and were placed in a constant-temperature incubator at 37 °C. After 7 days of immersion, the samples were retrieved. They were subsequently ultrasonically cleaned sequentially in anhydrous ethanol and deionized water for 5 min each, followed by drying. The corrosion morphology of the samples from both the experimental and control groups was examined using an SEM. In vitro long-term immersion test Sample preparation and immersion protocol Ten CaP-coated AZ31 magnesium alloy rib-embracing plates were assigned as the experimental group, and ten uncoated AZ31 magnesium alloy plates served as the control group. The samples were cleaned and dried according to the aforementioned method. The initial mass (M0) of each sample was accurately measured using an electronic balance, and the samples were subsequently numbered. The average initial mass was 2.00 g ± 0.02 g for the experimental group and 1.98 g ± 0.03 g for the control group. Each sample from both groups was individually immersed in a flask containing 150 mL of SBF. The liquid height was maintained at approximately five times the sample height. The flasks, kept open to the ambient atmosphere, were placed in a constant-temperature incubator at 37 °C. The immersion experiment was conducted over a total period of 8 weeks. Throughout this period, the samples were visually inspected weekly, and the immersion solution was completely replaced with fresh SBF each time. During solution changes, care was taken to minimize disturbance to the samples. Calculation of degradation rate After the 8-week immersion period, the samples were removed from the SBF and immersed in a 10% acetic acid solution for 3 min to completely remove the surface degradation products. They were subsequently ultrasonically cleaned sequentially in anhydrous ethanol and deionized water for 5 min each and dried. The final mass (M1) of each treated sample was accurately measured using an electronic balance. The degradation rate of each sample was then calculated using the formula: CR = ΔW/(S × T). Where CR=Degradation rate (mg/cm²/day);ΔW = M0 − M1(mg);S=Surface area of the sample (cm²);T=Immersion time (days). In vivo degradation experiment Experimental grouping Fifteen miniature pigs (provided by Taizhou Taihe Biotechnology Co., Ltd.), regardless of sex, were randomly divided into three groups with five animals in each group. A within-group self-control design was adopted for all groups, wherein one side of the ribs in each animal was fixed with a CaP-coated magnesium alloy plate, while the contralateral side received different control treatments according to the group assignment. The three groups were designated as: CaP-coated vs. Unfixed group, CaP-coated vs. Uncoated group, and CaP-coated vs. Ni-Ti group. All study procedures comply with the ARRIVE guidelines and were approved by the Animal Ethics and Welfare Committee of Zhejiang Chinese Medical University(Approval number:20231023-17). Sample preparation Prior to implantation, both the magnesium alloy and CaP-coated magnesium alloy rib-embracing plates were cleaned and dried as described previously. The initial mass (M0) of each sample was accurately measured using an electronic balance, and all samples were subsequently numbered. Following the weighing procedure, all samples were sterilized using ethylene oxide sterilization. Animal anesthesia The experimental pigs were fasted for 12 h preoperatively. Anesthesia was induced via intramuscular injection in the gluteal region with atropine (0.02 mg/Kg), Sumianxin (0.1 mL/Kg), and pentobarbital sodium (3 mg/Kg). Following tracheal intubation, mechanical ventilation was maintained using an anesthesia machine. Vital signs were monitored throughout the procedure, and anesthesia depth was sustained by continuous intravenous infusion of propofol and inhalation of isoflurane. Establishment of the rib fracture animal model and fixation with different methods (Fig. 1c) Miniature pigs have 14 pairs of ribs. The first and second ribs were excluded from the surgical procedure due to their deep anatomical location and the presence of major adjacent blood vessels, which make dissection challenging. The 14th rib, being a floating rib with high mobility, was also excluded. Prior to the experiment, a lottery method was used to randomly select four consecutive numbers from 3 to 13. These four identified rib pairs were designated for surgical intervention and labeled as R1, R2, R3, and R4 ribs. This randomization procedure was repeated five times to assign specific operative ribs for the five miniature pigs within each experimental group. Following successful anesthesia, the miniature pigs were positioned in lateral recumbency and secured on the operating table. The surgical site was shaved using an electric clipper, followed by skin disinfection with povidone-iodine. Sterile drapes and surgical adhesive films were applied. Sequential incisions were made through the skin and subcutaneous tissue to expose the R1 to R4 ribs bilaterally at the level of the mid-axillary line. A bone rongeur was used to create clean, transverse osteotomies of the exposed ribs on both sides, thereby establishing the rib fracture animal model. Different treatment modalities were applied to the rib fractures in the various groups, as illustrated in Fig. 1c. In the CaP coated vs. Unfixed group, four fractures on one side were fixed using the CaP coated AZ31 magnesium alloy rib-embracing plate (Fig. 1d), while the four contralateral fractures were only reduced without fixation (Fig. 1e); in the CaP coated vs. Uncoated group, four fractures on one side were fixed with the CaP coated AZ31 magnesium alloy plate, and the four contralateral fractures were fixed with the uncoated AZ31 magnesium alloy plate (Fig. 1f); in the CaP coated vs. Ni-Ti group, four fractures on one side were fixed with the CaP coated AZ31 magnesium alloy plate, and the four contralateral fractures were fixed with a Ni-Ti shape memory alloy plate (Fig. 1g). All fixations ensured anatomical reduction, followed by layered wound closure under aseptic protocols. After surgery, the endotracheal tube was extubated upon the return of spontaneous motor reflexes. The animals were housed individually. For the first two postoperative weeks, all miniature pigs received daily intramuscular injections of penicillin (30,000 IU/Kg) and had their surgical incisions sprayed with povidone-iodine to prevent infection. All animals were humanely euthanized 6 months postoperatively. Radiographic evaluation At 3 months postoperatively, all miniature pigs underwent thoracic X-ray examination using a digital radiography system (VET1800B, Zhuhai Puli Medical). The images were assessed to observe the fracture healing status and callus formation at the fracture sites, as well as to conduct a preliminary evaluation of the degradation state of both the uncoated and CaP-coated AZ31 magnesium alloy rib-embracing plates. Direct visual observation and measurement At 6 months postoperatively, the original surgical incision was reopened through sequential dissection of the skin and subcutaneous tissues. All internal fixation plates were explanted. An approximately 4-cm-long rib segment centered on the fracture line was resected for gross specimen observation. The transverse and longitudinal displacement distances at the proximal and distal ends of the fracture were measured using a vernier caliper. Healing was defined as follows: (Transverse displacement distance/Rib width) ≤ 20% or (Longitudinal displacement distance/Rib thickness) ≤ 20% was defined as good healing; 20% < (Transverse displacement distance/Rib width) ≤ 50% or 20% < (Longitudinal displacement distance / Rib thickness) ≤ 50% was defined as mild malunion; (Transverse displacement distance/Rib width) > 50% or (Longitudinal displacement distance/Rib thickness) > 50% was defined as severe malunion. The explanted magnesium alloy and CaP-coated magnesium alloy rib-embracing plates were observed. Adherent tissues and blood were thoroughly removed from their surfaces. The plates were then immersed in a 10% acetic acid solution for 3 min to remove attached degradation products, followed by sequential ultrasonic cleaning in anhydrous ethanol and deionized water for 5 min each, and finally dried. The mass (M1) of each processed sample was accurately measured using an electronic balance. The degradation rate of each sample was calculated according to the formula :CR = ΔW/(S × T). CR represents the degradation rate (mg/cm²/day); ΔW represents the mass loss before and after implantation, calculated as M0- M1 (mg); S represents the surface area of the sample (cm²); T represents the implantation time (days). Histological analysis A bone tissue specimen of approximately 2.0 cm × 1.0 cm × 0.5 cm was harvested from the fracture center of the resected rib segment. The specimen was processed into sections with a thickness of 5 μm and subjected to hematoxylin-eosin (HE) staining. The stained sections were then examined under a light microscope (at 100× magnification) to observe the presence and morphology of osteoblasts, osteocytes, bone trabeculae, and newly formed capillaries. Recording the adverse effects of the Rib-embracing plates Postoperatively, the surgical incisions were observed and recorded daily for the presence of subcutaneous emphysema, infection, effusion, and for the occurrence of any animal mortality. Blood samples were collected from the marginal ear vein of all miniature pigs preoperatively and at 3 and 6 months postoperatively. The following parameters were measured in serum: calcium ion concentration [Ca²⁺], magnesium ion concentration [Mg²⁺], phosphate ion concentration [Pi], creatinine (Cr), urea nitrogen (BUN), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), creatine kinase isoenzyme (CK-MM), white blood cell (WBC) count, red blood cell (RBC) count, platelet (PLT) count, hemoglobin (Hb), and neutrophil percentage (NEUT %). Statistical analysis Data analysis was performed using the SPSS 28.0 statistical software. Continuous data that followed a normal distribution are expressed as mean ± standard deviation (Mean ± SD).In the in vitro degradation experiment, comparisons between two samples with equal population variances were conducted using the t-test, while an approximate t-test was used for comparisons with unequal variances. For the in vivo degradation experiment, when comparing multiple groups, one-way analysis of variance (ANOVA) was employed if the data were normally distributed and variances were homogeneous; if the data were non-normally distributed or variances were unequal, the Kruskal-Wallis H test was used. If the H test indicated a significant difference, the Dunn test was applied for post-hoc pairwise comparisons. For within-group comparisons, the paired samples t-test was selected if the differences were normally distributed; otherwise, the Wilcoxon signed-rank test was used. For the statistical analysis of blood test indicators, the two-way mixed-design ANOVA was primarily used. If the data did not meet the assumptions of normality, homogeneity of variance, or sphericity, separate between-group and within-group comparisons were performed: between-group comparisons used the Kruskal-Wallis test, while within-group comparisons used the Friedman test. A P-value < 0.05 was considered statistically significant. Results Structural characterization and analysis Figure 2a, b display the surface and cross-sectional morphology of the CaP-coated AZ31 magnesium alloy sample, respectively. As depicted in Fig. 2a, the sample exhibits uniform grain size and a dense surface structure. Figure 2b shows that the CaP coating on the surface of the FCVA-pretreated AZ31 magnesium alloy sample is relatively uniform in thickness, with an average thickness of approximately 10.3 μm. No cracks or delamination are observed in its lower region, and a continuous and compact interface is formed between the coating and the substrate. Figure 2c presents the TEM image of the coating. It can be observed that the coating is primarily composed of granular and flake-shaped phosphate particles. Upon magnification, numerous spherical clusters are visible within the coating (Fig. 2d). Figure 2e presents the XRD diffraction patterns of all samples. The diffraction peaks of magnesium are essentially consistent across all samples. Additionally, the main components of the coating—tricalcium hydrogen phosphate(Ca3H2P4O14) and tricalcium phosphate (Ca3(PO4)2)—were detected in the CaP-coated samples. The characteristic peak of Ca3(PO4)2 appears at 2θ ≈ 34.3°, while the characteristic peaks of Ca3H2P4O14 are located near 2θ ≈ 26.4° and 67.1°. Figure 2f shows the FTIR spectral analysis results of the CaP-coated magnesium alloy samples. The infrared spectra of all CaP coatings display characteristic absorption peaks for phosphate compounds (PO4³⁻and HPO4²⁻): the absorption peak at 1042 cm−1 corresponds to the asymmetric stretching vibration of PO4³⁻, and the peak at 851 cm−1 originates from the P–O bond vibration. The absorption peak at 1392 cm−1 is attributed to the symmetric stretching vibration of phosphate groups. The broad weak peaks observed in the 2600–3600 cm−1 range are due to the stretching/bending vibrations of water molecules, indicating the presence of unavoidable adsorbed water interference during the experiment. SEM morphology of the surface (a) and cross-section (b) of the CaP-coated magnesium alloy sample. TEM morphology (c) and corresponding magnified view (d) of the CaP coating. XRD patterns of the samples (e). FTIR spectroscopy spectra of the CaP-coated samples (f) Electrochemical tests Figure 3a presents the polarization curves of the different samples. The fitted corrosion current density (Icorr) and corrosion potential (Ecorr) data are shown in Fig. 3b. As shown, the CaP coating exhibits a more positive corrosion potential compared to the AZ31 magnesium alloy, indicating a lower tendency to corrode. Simultaneously, the CaP-coated sample demonstrates a lower corrosion current density, confirming its superior corrosion resistance. Tafel curve of samples (a). Polarization curve fitting parameters for different specimens (b). Surface corrosion morphologies of AZ31 samples (c) and CaP-coated samples(d) immersed in SBF solution for 7 days. AZ31 magnesium alloy samples (e) and CaP-coated AZ31 magnesium alloy samples (f) after degradation in in vitro experiments. In vitro degradation data of uncoated and CaP-coated AZ31 magnesium alloy samples (g) In vitro short-term immersion test After 7 days of immersion, the surface of the AZ31 magnesium alloy sample exhibited numerous intersecting cracks, resembling a dry riverbed (Fig. 3c), which represents a typical corrosion morphology for magnesium alloys. In contrast, the CaP-coated sample was significantly less corroded, with virtually no cracks observed on its surface (Fig. 3d). In vitro long-term immersion test After 1 week of immersion, numerous bubbles and a small amount of white precipitate were observed on the surface of the control group samples. Continuous bubble generation was observed on the sample surfaces, and the white precipitate gradually increased as the experiment progressed. By week 8, the sample surfaces were almost entirely covered by white precipitate. In the experimental group, a small number of bubbles were visible on the surface after 1 week. After 2 weeks, the bubble generation rate became similar to that of the control group, with a small amount of white precipitate appearing on the sample surfaces. This precipitate gradually increased over time, and by week 8, approximately 50% of the sample surfaces were covered. The structural integrity of both the experimental and control group samples remained intact throughout the entire experimental period. After the experiment, the samples were cleaned with a 10% acetic acid solution and dried. The control group samples showed a slight reduction in overall dimensions but a significant decrease in thickness. The substrate surface exhibited corrosion pits and holes of varying sizes, with a representative sample shown in Fig. 3e. The experimental group samples maintained essentially normal morphology and thickness. The substrate surface displayed corrosion pits of different sizes, and no coating adhesion was observed. A representative sample is shown in Fig. 3f. The mass (M1) of each sample after degradation was accurately measured using an electronic balance. The experimental group weighed 1.64 g ± 0.03 g, and the control group weighed 1.46 g ± 0.04 g. The degradation rate, calculated using the formula CR = ΔW/(S × t), was 0.31 mg/cm²/day ± 0.04 mg/cm²/day for the experimental group and 0.45 mg/cm²/day ± 0.04 mg/cm²/day for the control group. The difference in degradation rates in the SBF between the two groups was statistically significant (P < 0.001, Fig. 3g). In vivo degradation experiment Radiographic evaluation Figure 4a–c presents the chest X-ray findings of the experimental miniature pigs at 3 months postoperatively. In the CaP-coated vs. Unfixed group, where only reduction was performed without fixation, the rib fracture lines appeared blurred with noticeably enlarged callus formation at the fracture ends (Fig. 4a). For ribs fixed with the magnesium alloy rib-embracing plate (Fig. 4b), the CaP-coated magnesium alloy rib-embracing plate and the Ni-Ti shape memory alloy rib-embracing plate (Fig. 4c), no significant displacement was observed at the fracture sites. The fracture lines were obscured due to the shadowing effect of the embracing plates. All plates maintained satisfactory positioning. The magnesium alloy plates showed a slight reduction in size, while the other embracing plates retained normal morphology. The area indicated by the red arrow shows the unfixed fracture (a). The area indicated by the blue arrow shows the fracture fixed with the AZ31 magnesium alloy plate (b). The areas indicated by the yellow arrow and the green arrow show the fractures fixed with the CaP coated magnesium alloy plate and the Ni-Ti shape memory alloy plate, respectively (c). The uncoated AZ31 magnesium alloy embracing plate after degradation in the in vivo experiment (d). The CaP-coated AZ31 magnesium alloy embracing plate after degradation in the in vivo experiment (e). Histopathological section of rib bone tissue without any fixation (f). Histopathological section of rib bone tissue fixed with the uncoated magnesium alloy plate (g). Histopathological section of rib bone tissue fixed with the CaP-coated magnesium alloy plate (h). Histopathological section of rib bone tissue fixed with the Ni-Ti shape memory alloy plate (i) Direct visual observation upon surgical exposure In the CaP-coated vs. Unfixed group, the rib fracture ends that were only reduced but not fixed showed malunion. Markedly enlarged bony callus was observed at the fracture center. The transverse displacement distance was 5.7 mm ± 1.3 mm (displacement degree: 38.0%), and the longitudinal displacement distance was 5.1 mm ± 1.3 mm (displacement degree: 51.0%), which was classified as severe malunion. In the CaP-coated vs. Uncoated group, the fracture ends fixed with the magnesium alloy embracing plate were enveloped by an enlarged callus. The transverse displacement distance was 3.8 mm ± 0.9 mm (displacement degree: 25.0%), and the longitudinal displacement distance was 2.8 mm ± 0.7 mm (displacement degree: 28.0%), indicating mild malunion. The embracing plate exhibited reduced size and thinner thickness, with noticeable degradation on its inner side near the fracture ends. A representative sample is shown in Fig. 4d. The degradation percentage of the embracing plate was 23.2% ± 3.5%, with a degradation rate of 0.40 mg/cm²/day ± 0.06 mg/cm²/day. In the CaP-coated vs. Ni-Ti group, the ribs fixed with the Ni-Ti shape memory alloy embracing plate showed good healing, with hard bony callus formation at the fracture ends. The transverse displacement distance was approximately 2.1 mm ± 0.8 mm (displacement degree: 14.0%), and the longitudinal displacement distance was approximately 1.6 mm ± 0.7 mm (displacement degree: 16.0%), which was classified as good healing. The embracing plate maintained normal morphology. In all three groups, the ribs fixed with the CaP-coated magnesium alloy exhibited good healing, with the formation of hard bony callus at the fracture center. The embracing plates maintained normal morphology; however, corrosion pits of varying sizes and depths were observed on their surfaces. Significant corrosion was primarily located on the “claws” of the embracing plates, with a representative sample shown in Fig. 4e. In the CaP coated vs. Unfixed group, the transverse displacement distance of the rib fractures fixed with the CaP coated magnesium alloy embracing plate was 2.2 mm ± 1.1 mm (displacement degree: 14.7%), and the vertical displacement distance was 1.7 mm ± 0.5 mm (displacement degree: 16.5%), classified as good healing. The post-degradation mass of the embracing plate was 1.72 g ± 0.06 g, with a degradation percentage of 14.3% ± 3.2% and a degradation rate of 0.25 mg/cm²/day ± 0.06 mg/cm²/day. In the CaP-coated vs. Uncoated group, the transverse displacement distance of the rib fractures fixed with the CaP-coated magnesium alloy embracing plate was 2.3 mm ± 1.1 mm (displacement degree: 15.3%), and the vertical displacement distance was 1.8 mm ± 0.8 mm (displacement degree: 17.5%), classified as good healing. The post-degradation mass of the embracing plate was 1.73 g ± 0.06 g, with a degradation percentage of 13.9% ± 3.2% and a degradation rate of 0.24 mg/cm²/day ± 0.06 mg/cm²/day. In the CaP-coated vs. Ni-Ti group, the transverse displacement distance of the rib fractures fixed with the CaP-coated magnesium alloy embracing plate was 2.2 mm ± 0.8 mm (displacement degree: 14.3%), and the vertical displacement distance was 1.9 mm ± 0.7 mm (displacement degree: 18.5%), classified as good healing. The post-degradation mass of the embracing plate was 1.73 g ± 0.06 g, with a degradation percentage of 13.7% ± 3.1% and a degradation rate of 0.24 mg/cm²/day ± 0.05 mg/cm²/day. The intergroup comparison results demonstrated that for the ribs on the side fixed without the CaP-coated magnesium alloy rib-embracing plates across the three groups, the differences in both transverse and longitudinal fracture displacement distances were statistically significant (p < 0.001, Table 2). Post-hoc pairwise comparisons revealed the order of fracture displacement distances as: CaP-coated vs. Unfixed group > CaP-coated vs. Uncoated group > CaP-coated vs. Ni-Ti group. Conversely, for the ribs on the side fixed with the CaP-coated magnesium alloy rib-embracing plates, no statistically significant differences were observed in the transverse fracture displacement distance, longitudinal fracture displacement distance, mass after degradation, degradation percentage, or degradation rate (P > 0.05). Within the CaP-coated vs. Uncoated group, the degradation rate of the CaP-coated magnesium alloy rib-embracing plates was significantly lower than that of the uncoated magnesium alloy plates, and this difference was statistically significant (P < 0.05). Results of within-group comparisons showed that: In the CaP-coated vs. Unfixed group, the differences in both transverse and longitudinal fracture displacement distances were statistically significant (p < 0.05). The fracture displacement distances in ribs fixed with the CaP-coated magnesium alloy rib-embracing plates were significantly smaller than those in ribs that received no fixation. In the CaP-coated vs. Uncoated group, statistically significant differences (p < 0.05) were observed in the transverse fracture displacement distance, longitudinal fracture displacement distance, post-degradation plate mass, degradation percentage, and degradation rate. The degree of fracture displacement on the side fixed with the CaP-coated magnesium alloy rib-embracing plates was significantly smaller than on the side fixed with the uncoated magnesium alloy plates. Furthermore, the degradation mass, degradation percentage, and degradation rate of the CaP-coated plates were all significantly lower than those of the uncoated magnesium alloy plates. In the CaP-coated vs. Ni-Ti group, no statistically significant differences were found in the transverse and longitudinal fracture displacement distances (p > 0.05). The degree of fracture displacement in ribs fixed with the CaP-coated magnesium alloy plates was similar to that in ribs fixed with the Ni-Ti alloy plates. Table 2Fracture Displacement and Implant Degradation Data in the In Vivo ExperimentCaP-coated vs. Unfixed groupCaP-coated vs. Uncoated groupCaP-coated vs. Ni-Ti groupP value*Fracture Transverse Displacement Distance (mm)2.2 ± 1.1 vs. 5.7 ± 1.32.3 ± 1.1 vs. 3.8 ± 0.92.2 ± 0.8 vs. 2.1 ± 0.80.062 vs. <0.001Fracture Longitudinal Displacement Distance (mm)1.7 ± 0.5 vs. 5.1 ± 1.31.8 ± 0.8 vs. 2.8 ± 0.71.9 ± 0.7 vs. 1.6 ± 0.70.127 vs. <0.001Mass before degradation (g)2.00 ± 0.02 vs. N/A2.00 ± 0.03 vs. 1.98 ± 0.022.00 ± 0.03 vs. N/A0.855 vs. N/AMass after degradation (g)1.72 ± 0.06 vs. N/A1.73 ± 0.06 vs. 1.52 ± 0.071.73 ± 0.06 vs. N/A0.923 vs. N/ADegradation Percentage (%)14.3 ± 3.2 vs. N/A13.9 ± 3.2 vs. 23.2 ± 3.513.7 ± 3.1 vs. N/A0.924 vs. N/ADegradation Rate (mg/cm2/day)0.25 ± 0.06 vs. N/A0.24 ± 0.06 vs. 0.40 ± 0.060.24 ± 0.05 vs. N/A0.144 vs. N/A*Significance level P < 0.05 Fracture Displacement and Implant Degradation Data in the In Vivo Experiment *Significance level P < 0.05 Pathological findings Qualitative histological examination of HE-stained bone tissue sections revealed distinct morphological differences among the groups: In ribs without any fixation, the bone tissue sections at the fracture center showed extensive local fibrous tissue hyperplasia, sparse osteocytes and osteoblasts, disorganized and sparse arrangement of bone trabeculae, and the presence of newly formed capillaries between the trabeculae (Fig. 4f). In ribs fixed with the uncoated magnesium alloy plate, the bone tissue sections exhibited surface fibrous tissue hyperplasia, uniformly distributed osteocytes, orderly arranged bone trabeculae lined with actively proliferating osteoblasts, and newly formed capillaries between the bone trabeculae (Fig. 4g). The histological appearances of ribs fixed with the CaP coated magnesium alloy plate and the Ni-Ti shape memory alloy plate were similar to those described for the uncoated magnesium alloy group. However, these groups demonstrated a greater quantity of bone trabeculae and newly formed capillaries (Fig. 4h, i). Adverse effects All experimental miniature pigs survived the entire postoperative period without any complications. Normal daily activity, responsiveness, and feeding behavior were maintained in all animals. The surgical incisions healed normally, with no occurrences of subcutaneous emphysema, effusion, or infection observed. Within-group comparisons: Repeated-measures ANOVA results (Fig. 5a–i) showed that in the CaP coated vs. Uncoated group, serum [Mg²⁺], Cr, and BUN levels followed a statistically significant increasing trend (6 months postoperative > 3 months postoperative > preoperative; p < 0.001), while no statistically significant differences over time were observed in the same group for [Ca²⁺], [Pi], ALT, AST, CK and CK-MM, WBC count, RBC count, PLT count, Hb, and NEUT % (p > 0.05). Furthermore, in both the CaP-coated vs. Unfixed group and the CaP-coated vs. Ni-Ti group, none of the tested parameters showed statistically significant differences over time (p > 0.05). Serum levels of various parameters in the CaP-coated vs. Unfixed group preoperatively, and at 3 and 6 months postoperatively (a–c). Serum levels of various parameters in the CaP-coated vs. the uncoated group preoperatively, and at 3 and 6 months postoperatively (d–f). Serum levels of various parameters in the CaP-coated vs. Ni-Ti group preoperatively, and at 3 and 6 months postoperatively (g–i) Between-group comparisons: One-way ANOVA results (Fig. 6a–i) revealed that at both 3 and 6 months postoperatively, the CaP coated vs. Uncoated group exhibited significantly elevated levels of serum [Mg²⁺], Cr, and BUN compared to both the CaP coated vs. Unfixed group and the CaP coated vs. Ni-Ti group (p < 0.001), while no statistically significant differences were observed in these parameters between the CaP coated vs. Unfixed group and the CaP coated vs. Ni-Ti group (p > 0.05); preoperatively, no statistically significant differences were detected in [Mg²⁺], Cr, and BUN levels among the three groups (p > 0.05); additionally, at all time points (preoperative, 3 months postoperative, and 6 months postoperative), no statistically significant intergroup differences were found for [Ca²⁺], [Pi], ALT, AST, CK and CK-MM, WBC count, RBC count, PLT count, Hb, and NEUT % (p > 0.05). Preoperative serum levels of various parameters in each group (a–c). Serum levels of various parameters in each group at 3 months postoperatively (d–f). Serum levels of various parameters in each group at 6 months postoperatively (g–i) Discussion AZ31 magnesium alloy is a novel biodegradable biomedical metallic material with a density of 1.78 g/cm³ and an elastic modulus close to that of human natural bone [13]. It exhibits significant clinical application potential in the field of internal bone fixation due to its excellent mechanical properties and good biocompatibility [14, 15]. In the physiological environment, magnesium readily undergoes electrochemical corrosion, converting into highly soluble magnesium chloride and hydrogen gas, leading to its degradation. Excess magnesium in the body can be excreted via urine without causing toxic reactions [16]. However, the relatively rapid degradation rate of magnesium in vivo can lead to premature failure of its fixation function, and the substantial amount of hydrogen gas generated within a short period may accumulate around the implant, which is detrimental to fracture healing and the surrounding tissues [17]. In 1906, Lambotte first implanted a pure magnesium plate in a patient for fixing a lower limb fracture; however, the implant had to be removed due to significant gas formation, causing swelling and pain in the surgical area [18]. With ongoing research on magnesium alloy materials, numerous in vitro studies have indicated that surface coating treatment can effectively decelerate the degradation rate of magnesium alloys. Therefore, we selected the commonly used biodegradable medical magnesium alloy AZ31 as the base material and applied a hybrid “FCVA deposition + chemical conversion” method to fabricate a CaP coating on its surface. Through comparative in vitro and in vivo experiments, we observed that the degradation rate of the AZ31 magnesium alloy with a surface CaP coating was significantly reduced. This helps address the series of issues arising from the excessively rapid in vivo degradation of conventional AZ31 magnesium alloy. In this study, a CaP coating was fabricated on the surface of AZ31 magnesium alloy via a combined “FCVA deposition and chemical conversion” method. XRD analysis results (Fig. 2e) reveal that the coating exhibits broad and low-intensity diffraction peaks, which can be attributed to Ca3(PO4)2 and Ca3H2P4O14, while no sharp characteristic peaks corresponding to well-crystallized stoichiometric hydroxyapatite were detected. Combined analysis of the distinct HPO4²⁻ characteristic peaks and the broad absorption band in the range of 3000–3500 cm⁻¹ (assigned to OH groups and adsorbed H2O) in the FTIR spectrum (Fig. 2f) indicates that the CaP coating is essentially a multiphase composite system, primarily composed of amorphous CaP, poorly crystalline tricalcium phosphate, and calcium-deficient apatite. This phase composition is intentionally designed to mimic the metastable and highly reactive characteristics of early-stage bone mineral. It has been demonstrated that such amorphous or calcium‑deficient CaP phases exhibit higher solubility and superior bioactivity, thereby facilitating post‑implantation osseointegration and subsequent bone remodeling [19, 20]. In the short-term in vitro degradation experiment, scanning electron microscopy revealed numerous cracks on the surface of the uncoated AZ31 magnesium alloy samples after immersion in SBF. In contrast, the surface of the CaP-coated magnesium alloy samples remained largely free of cracks, demonstrating the superior corrosion resistance of the coated material. Furthermore, the long-term in vitro degradation experiment showed that after 8 weeks of immersion in SBF, the uncoated AZ31 magnesium alloy embracing plates exhibited a significant reduction in thickness and the development of pores within the substrate. Conversely, the CaP-coated plates maintained their original thickness without notable change, displaying only corrosion pits of varying sizes on the substrate surface. These observations further confirm that the CaP coating effectively retards the degradation of the magnesium alloy. We found by calculation that the CaP-coated magnesium alloy exhibited a slower degradation rate in SBF compared to the uncoated alloy, which is similar to the findings reported by Cui et al. [21]. Calcium and phosphorus are essential inorganic components of bone tissue. The primary mechanism by which the coating decelerates the degradation rate of the magnesium alloy involves the formation of a dense physical barrier on the metal surface. This layer directly isolates the magnesium alloy substrate from bodily fluids, thereby retarding the penetration of corrosive media [22]. Furthermore, the CaP coating not only slows the degradation rate of the magnesium alloy but also demonstrates the ability to stimulate the formation of new bone tissue. As shown in Fig. 2a, the CaP coating produced uniform and dense micro-protrusions on the magnesium alloy surface, significantly increasing its roughness and thus creating favorable conditions for osteoblast adhesion [23]. In their study, Gao et al. [22] implanted magnesium alloy rods with a surface CaP coating into the femurs of New Zealand rabbits. At 3 months post-implantation, osteoid tissue and newly formed bone trabeculae were observed to almost entirely cover the implant surface. Furthermore, compared to uncoated magnesium alloy implants, those with the CaP coating exhibited an increased quantity and more orderly arrangement of newly formed bone trabeculae around the implant. This newly formed bone tissue, covering the metal substrate, creates a “biological barrier” that can further decelerate the degradation rate of the magnesium alloy. In the long-term in vitro degradation experiment, the coating exhibited a biphasic characteristic: with a slow initial phase followed by an accelerated later phase. We attribute this phenomenon to the protective effect of the coating during the initial phase of the experiment, which prevented full contact between the magnesium alloy substrate and the SBF, thus slowing degradation. After 2 weeks, as the CaP coating on the magnesium alloy surface gradually degraded and delaminated, the contact area between the substrate and the SBF increased, leading to a gradual acceleration of the degradation rate. This behavior aligns well with the design requirements for an ideal biodegradable implant: providing stable mechanical support during the early phase of fracture healing, while accelerating degradation in the later healing stage to avoid long-term stress shielding. In this study, we selected swine as the experimental animal model for establishing the rib fracture surgical model. This choice was based on the close similarities between swine and humans in terms of rib anatomy, histological structure, and biomechanical properties [24], which enhances the credibility and translational value of our experimental results. Postoperative chest X-rays of the experimental miniature pigs showed that, except for the fractures that were only reduced without fixation—which resulted in malunion—no significant displacement was observed in the fractures fixed with the three different types of rib-embracing plates. This underscores that effective internal fixation following fracture reduction is crucial for ensuring successful fracture healing. Owing to the limited resolution of chest X-rays, we performed a direct surgical re-exposure at the 6-month postoperative mark to enable more detailed observation and measurement of both fracture displacement and the degradation status of the embracing plates. The results demonstrated that the degradation rate of the CaP-coated magnesium alloy rib-embracing plates was significantly lower than that of their uncoated counterparts. Furthermore, the degree of fracture displacement in ribs fixed with the coated plates was smaller. This indicates that the slower degradation of the CaP-coated magnesium alloy plate may help maintain its structural integrity during the critical phase of fracture healing, thereby providing more stable support to the fracture site. Postoperative qualitative histopathological observation of the bone tissue from the fracture center revealed that ribs fixed with the CaP-coated plates exhibited a uniform distribution of normally shaped osteoblasts and osteocytes, clearly defined and orderly arranged bone trabeculae. Compared with those fixed using the uncoated plate, the bone-healing interface in the CaP-coated group showed a morphological trend toward richer trabeculation and more active vascularization. This morphological trend aligns with the aforementioned quantitative data on fracture displacement and degradation, collectively indicating that the CaP coating creates favorable conditions for high-quality bone healing by providing a more stable mechanical environment. In the in vivo experiment, the degradation rate of the CaP-coated magnesium alloy rib-embracing plate was 0.24 mg/cm²/day, while that of the uncoated magnesium alloy plate was 0.40 mg/cm²/day. Both in vivo degradation rates were significantly slower than those observed in the in vitro experiments. This discrepancy is likely attributable to the differing degradation behaviors of magnesium alloy when in contact with various tissues in the body versus the simulated in vitro environment. The chemical reactions for magnesium degradation in vivo are as follows [25]: Anodic dissolution: Mg → Mg²⁺ + 2e⁻ Anodic dissolution: Mg → Mg²⁺ + 2e⁻ Cathodic reduction: 2H₂O + 2e⁻ → H₂↑ + 2OH⁻ Cathodic reduction: 2H₂O + 2e⁻ → H₂↑ + 2OH⁻ Precipitation: Mg(OH)₂↓ + 2Cl⁻ → MgCl₂ + 2OH⁻ Precipitation: Mg(OH)₂↓ + 2Cl⁻ → MgCl₂ + 2OH⁻ In areas with rapid blood flow, Mg²⁺ and OH⁻ ions are promptly metabolized and cleared from the body. In contrast, in regions with slower blood flow, these ions can undergo chemical reactions to form Mg(OH)₂, which precipitates on the surface of the magnesium alloy substrate, thereby decelerating its degradation rate. Kawamura et al. [26] implanted AZ31 magnesium alloy rods (1.6 mm in diameter, 4 mm in length) into the femurs of mice. Micro-CT 3D reconstruction images at 12 weeks post-implantation revealed significant degradation of the magnesium alloy in the bone marrow area with abundant blood supply, whereas degradation was not pronounced in regions contacting the cortical bone. They also suggested that the new bone formed on the surface of the magnesium alloy implant would reduce the contact area between the substrate and body fluids, further decreasing the corrosion rate. We speculate that in the in vitro experiments, the regular replacement of the SBF promptly removed Mg²⁺ and OH⁻ generated during the degradation process, reducing the formation of precipitates. Furthermore, the absence of new bone formation on the magnesium alloy surface in vitro likely contributed to the faster degradation rate observed. Additional studies have indicated that increased Cl⁻ concentration significantly accelerates the degradation rate of magnesium alloys. Song et al. [27] placed ternary Mg-Zn-Nd alloy filaments in both high Cl⁻concentration patient-derived peritoneal drainage fluid in vitro and in the gastrointestinal wall of New Zealand rabbits in vivo. They observed that the filaments completely degraded within only 6 days in the ex vivo setting, whereas the degradation process took up to 8 weeks in the in vivo environment. Cl⁻ can convert the Mg(OH)₂ precipitate formed on the magnesium alloy surface into highly soluble MgCl2. This reaction compromises the protective effect of the corrosion product layer. Furthermore, as active ions in the electrolyte, Cl⁻ accelerates both anodic dissolution and the cathodic hydrogen evolution reaction, thereby increasing the overall degradation rate. In human blood, the Cl⁻ concentration is approximately 135–145 mmol/L, whereas its content in muscle, nerve tissue, and bone is relatively low. The phosphate-buffered saline used in the in vitro experiments has a Cl⁻ concentration of about 140 mmol/L, which is similar to that in human blood but significantly higher than the Cl⁻ concentration in the environment surrounding the rib-embracing plate in vivo. This difference likely contributes to the faster degradation rate observed in vitro. Additionally, the presence of proteins in the in vivo environment may also influence the degradation rate. Johnson et al. [28] suggested that protein adsorption on metal surfaces can form a physical barrier, protecting the surface from electrolytes and aggressive ions. Negatively charged proteins exhibit a stronger attraction to cathodic sites on the degrading metal and can inhibit degradation by competing with Cl⁻ for adsorption sites. Sanchez et al. [29] summarized the in vitro and in vivo degradation behaviors of more than 20 types of magnesium and its alloys, finding that the in vitro degradation rates were generally 1 to 4 times higher than those in vivo. They attributed this discrepancy, in part, to the difficulty in fully replicating the complex physiological conditions in vitro. Chromic acid is considered the “gold standard” for cleaning corrosion products from magnesium alloys. However, due to its classification as a highly toxic, carcinogenic, and environmentally hazardous chemical, we opted for the safer and milder alternative of acetic acid solution in our experiments. We acknowledge that, compared to chromic acid, acetic acid may cause slight etching of the magnesium substrate [30, 31], which could lead to a systematic overestimation of the absolute degradation rate. Nonetheless, since the primary objective of this study was to assess the relative difference in degradation behavior between CaP-coated and uncoated samples, and all experimental samples underwent an identical acetic acid cleaning procedure, the systematic bias introduced by this method remains relatively constant across both inter-group and intra-group comparisons. This ensures the reliability of the core conclusion that “the coating reduces the degradation rate.” Nevertheless, we recognize that the reported absolute degradation rate values should be interpreted with caution within this methodological context. In this experiment, all surgical incisions in the miniature pigs healed well, with no occurrence of the significant subcutaneous hydrogen gas accumulation previously reported in the literature [32] as being associated with excessively rapid in vivo degradation of magnesium alloys. This favorable outcome is likely attributable to the relatively slow degradation rate of both the uncoated and CaP-coated magnesium alloy embracing plates in the porcine model. The rate of hydrogen gas absorption by the body appears to have maintained a dynamic equilibrium with its rate of generation. In this study, a potentially clinically significant trend of renal function impairment was observed in the CaP-coated vs. the uncoated group. In this group, serum [Mg2+], Cr, and BUN levels showed a progressive increase at 3 and 6 months postoperatively, whereas these parameters were within the normal range in the other two groups that did not receive uncoated magnesium alloy fixation. This suggests that the degradation of uncoated magnesium alloy may lead to renal function impairment. Regarding the cause of renal injury, Radha et al. [33] suggested that when the degradation rate of a magnesium alloy implant is too rapid, excessive release of magnesium ions can accumulate in the kidneys, producing toxic effects. Ma et al. [34] implanted both CaP-coated and uncoated WE43 magnesium alloy rods into rats for the fixation of tibial fractures and collected blood samples at various postoperative time points. They found that serum magnesium ion concentrations in rats with uncoated magnesium alloy rods were significantly higher at all time points compared to those with coated implants. However, findings different from these have also been reported. Zhao et al. [35] implanted three types of circular magnesium alloy discs with different degradation rates subcutaneously in mice. One month later, inductively coupled plasma mass spectrometry (ICP-MS) analysis of magnesium ion content in various organs revealed that the three magnesium alloys, including AZ31, did not cause significant magnesium accumulation. The authors attributed this finding to the relatively low chloride ion concentration in the subcutaneous tissue of mice, which resulted in a slower degradation rate of the magnesium alloys, suggesting that the degradation behavior of magnesium alloys is environment-dependent. Compared to the CaP coated vs. Uncoated group, no hypermagnesemia or significant elevations in Cr and BUN levels were observed postoperatively in either the CaP coated vs. Unfixed group or the CaP coated vs. Ni-Ti group, indicating that the CaP coating, by slowing the degradation rate of the magnesium alloy, prevented the rapid release and accumulation of magnesium ions and, to some extent, reduced the risk of renal injury. Furthermore, Ho et al. [36] also found that the CaP coating can significantly improve the hemocompatibility, biocompatibility, and cell adhesion of AZ31 magnesium alloy. Although the trend of renal function impairment observed in this experiment appeared only in the CaP coated vs. Uncoated group, this finding provides direction for future research: in subsequent experiments, systematic renal function assessment must be incorporated into core observation indicators, including estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (UACR), cystatin C, and markers of renal tubular injury, combined with renal histopathological examination, to determine the threshold, reversibility, and mechanisms of injury. This will provide critical data for establishing the “biosafety window” for the degradation rate of magnesium alloys. In clinical practice, internal fixation materials are often subjected to multi-directional stresses from the surrounding fracture site. If the strength of the implant is insufficient, it may undergo deformation or even fracture, leading to premature failure of the fixation. However, through an extensive literature review, we found that the vast majority of previous studies on the in vivo degradation of magnesium alloy materials merely involved placing the implants within animal bodies—such as in the bone marrow cavity, muscle, or subcutaneous tissue—where the magnesium alloy materials were not subjected to mechanical stress during implantation. To address this limitation, we innovatively established a rib fracture model in miniature pigs and allowed the animals normal postoperative activity. This approach simulated the stress conditions experienced by the AZ31 and CaP-coated AZ31 magnesium alloy embracing plates during the fracture healing process, thereby providing a more realistic representation of the degradation behavior of magnesium alloy materials in the context of fracture fixation. However, this study has several limitations: First, the assessment of fixation stability relied primarily on indirect inferences from imaging and biological outcomes, lacking direct mechanical performance tests (e.g., bending stiffness, fatigue resistance) on the CaP-coated magnesium alloy plate; future work should include in vitro simulations of physiological loading and in vivo biomechanical studies to address this gap. Second, due to the constraints of the experimental timeline, animals were euthanized at 6 months post-operation, which precluded observation of the complete degradation process and the long-term biocompatibility of the material; subsequent studies should extend to large-animal experiments lasting 6–12 months or longer, with systematic evaluation of the metabolism and accumulation of degradation products in major organs. Third, the sample size was relatively small, which may limit statistical power and the generalizability of the conclusions; expanding the sample size and pursuing multi-center validation in future research would enhance the reliability of the findings. Conclusion This study, through both in vitro and in vivo experiments, confirms that modifying the surface of AZ31 magnesium alloy with a CaP coating effectively slows its degradation rate. By implanting the CaP-coated AZ31 magnesium alloy plates into a large animal model, we found that they degraded at a controllable rate, effectively maintained fracture alignment throughout the healing period, and showed no significant toxic side effects on the body during the 6-month postoperative observation period. This indicates that the CaP coating technology helps address the issue of fixation failure caused by excessively rapid in vivo degradation of biodegradable magnesium alloys. Overall, this study provides valuable experimental data and novel insights for the research and design of biodegradable rib internal fixation materials. However, its eventual clinical translation will depend on future systematic and in-depth investigations into long-term degradation kinetics, in vivo mechanical performance, and biosafety. Supplementary information Original data of the MS Author contributions Bo Ye and Ke Chen proposed the conception and designed the research. Qihong Huang, Sike Mo and Xuhui Liu conducted all the experiments and wrote the manuscript. Shu Yang, Juan Liu and Xiangqing Ye processed the original data. Keyuan Liu and Fugang Qi review the manuscript. All authors read and approved the final manuscript. Funding This work was supported by funding from the People’s Republic of China, Zhejiang Medical and Health Science and Technology Project, with grant number 2023RC233. Compliance with ethical standards Conflict of interest The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Xuhui Liu, Email: XuHuiliu1997@163.com. Bo Ye, Email: 16996881@qq.com. Supplementary information The online version contains supplementary material available at 10.1007/s10856-026-07085-4. References Associated Data Supplementary Materials Original data of the MS